Publicaciones en colaboración con investigadores/as de Hospital de Cruces (16)

2023

  1. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

2022

  1. MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice

    Diagnostics, Vol. 12, Núm. 1

2021

  1. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

    Neurology, Vol. 97, Núm. 14, pp. E1367-E1381

  2. Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project

    Brain Sciences, Vol. 11, Núm. 8

2020

  1. Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study

    Journal of Neuro-Oncology, Vol. 148, Núm. 3, pp. 545-554

2019

  1. Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 65, pp. 139-145

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

  2. Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 3, Núm. 3

2015

  1. Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

    Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

2013

  1. Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)

    Neurologia, Vol. 28, Núm. 8, pp. 503-521

  2. Enfermedad de Parkinson avanzada. Características clínicas y tratamiento. Parte II

    Neurologia, Vol. 28, Núm. 9, pp. 558-583

2012

  1. levodopa en el tratamiento de la enfermedad de parkinson: Mitos y realidades

    Revista de Neurologia, Vol. 55, Núm. 11, pp. 669-688

2010

  1. Efficacy and safety of pallidal stimulation in primary dystonia: Results of the Spanish multicentric study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 81, Núm. 1, pp. 65-69

2009

  1. Neuroprotección en la enfermedad de parkinson: Análisis a través de la metodología de informadores clave

    Neurologia, Vol. 24, Núm. 2, pp. 113-124

2008

  1. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

    Movement Disorders, Vol. 23, Núm. 8, pp. 1130-1136